|Bid||15.31 x 2900|
|Ask||15.49 x 3200|
|Day's Range||15.20 - 15.53|
|52 Week Range||7.54 - 18.34|
|Beta (5Y Monthly)||1.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 03, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.25|
Over the course of six years, U.S. Sen. David Perdue has placed 2,596 stock trades. Some of the trades may have involved possible inside information thanks to his position on several Senate sub-committees.What Happened: The New York Times published an in-depth look at Perdue's history of trades during his term as a senator.The Republican from Georgia faces a run-off election for his seat in January.Over six years, Perdue was the most active stock trader in the Senate, sometime buying and selling more than 20 times a day. The trades by Perdue totaled around one-third of all trades by senators during this time. His trading volume was more than the next five most active traders combined. The Justice Department has investigated Perdue for possible insider trading, but declined to bring charges, the report said. Perdue has said all of his trades were handled by outside advisors, but the article notes he told Goldman Sachs to sell a specific stock on at least one occasion.Related Link: Why FireEye's Stock Is Trading Higher TodayCybersecurity Wins: Perdue was a member of a cybersecurity subcommittee in the U.S. Senate.From 2016 to 2020, Perdue bought and sold cybersecurity company FireEye Inc (NASDAQ: FEYE). At one point, Perdue owned $250,000 in FireEye shares.Half of Perdue's trades in FireEye came when he was a member of the cybersecurity subcommittee.FireEye landed a $30-million U.S. Army contract that Perdue may have known about before it was publicly announced.Perdue had capital gains from his FireEye sales of over $15,000 in 2018.Perdue also made $15,000 to $50,000 in capital gains when he sold BWX Technologies Inc (NYSE: BWXT). The company supplies nuclear components and landed several contracts from the U.S. Navy.Financial Stocks: Perdue was a member of the Senate Banking, Housing and Urban Affairs Committee. Bank stocks Perdue sold during his time in Congress include JPMorgan Chase (NYSE: JPM), Bank of America Corporation (NSYE:BAC) and Regions Corporation (NYSE: RF).Perdue bought shares of Regions Financial on more than 30 occasions in 2017 and 2018. Perdue pushed to roll back financial regulations and co-sponsored a bill that proposed to soften the regulations of mid-size banks like Regions.Regions shares were up 35% when President Donald Trump signed the bill into law.John Turner, the CEO of Regions Financial, has contributed to Perdue's re-election campaign.Pandemic Stocks: In April, Perdue was one of several Senators who faced criticism over trading shares of companies that stood to benefit from the COVID-19 pandemic.Perdue sold shares of several names after a Jan. 24 meeting held to discuss the pandemic. Perdue's office said he did not attend the briefing.Perdue bought $260,000 in Pfizer Inc (NYSE: PFE) shares between Feb. 26 to Feb. 28, before the company announced a partnership with BioNTech (NASDAQ: BNTX) on a COVID-19 vaccine.Shares of DuPont (NYSE: DD), a company that provides personal protective equipment, was another stock bought by Perdue in the early stages of the pandemic.In February, Perdue sold all his stakes in Caesars Entertainment (NASDAQ: CZR), a casino operator that was later hurt due to travel restrictions and shutdown orders.What's Next: Perdue was one of several Senators who sold their stocks in April while in the spotlight due to trading during the COVID-19 pandemic.The Stock Act was passed eight years ago to try and prevent ethical issues tied to lawmakers buying and selling stock while serving in Congress.There is no law prohibiting trading stocks by members of Congress at this time. U.S. Senator Jeff Merkley believes the Stock Act doesn't go far enough, the Times reported. Merkley co-sponsored legislation that would ban the trading of individual stocks by members of Congress.Photo by Perdue for Senate via Wikimedia. See more from Benzinga * Click here for options trades from Benzinga * Cathie Wood Selling Slack Shares After Salesforce Acquisition * Clean Energy, Energy Storage Company STEM To Go Public Via SPAC(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
(Bloomberg) -- Nation-state hackers have been masquerading the past few months as one of the world’s largest cold-chain providers in a global email phishing scam seemingly aimed at spying on entities essential to the global distribution of Covid-19 vaccines, researchers said.X-Force, a digital security unit at force at International Business Machines Corp., discovered an email operation in which hackers claimed to represent Qingdao Haier Biomedical Co., a China-based company and one of the world’s largest cold-chain suppliers, making equipment to store and deliver materials at cold temperatures. In at least one copy of the spam email, the fake Haier representative sought to purchase about 500 vaccine refrigerators to bolster their temperature-controlled logistical services.The user, who purports to serve as Haier’s project manager in Africa, promised a $220,000 upfront payment, according to an email provided by the IBM security researchers. Attached to the email is a draft contract entitled, “RFQ - UNICEF CCEOP and Vaccine Project.” But the HTML attachment was actually a malicious file that, if opened, would prompt the recipient to share their secret login credentials with the attacker.IBM’s security team has been researching Covid-related cyber-attacks since the early days of the pandemic. Based on the sophistication of this attack, which targeted a variety of industries related to vaccine storage and delivery before hackers cleaned up their digital footprints, researchers believe the campaign was launched by a nation-state, but declined to speculate on which one.It’s unclear if any victims fell for the scam. But if they did, the harvested credentials could help an attacker “gain insight into internal communications, as well as the process, methods and plans to distribute a Covid-19 vaccine,” IBM Security said in a statement.As pharmaceutical companies and governments the world over prepare for the logistical puzzle of disseminating hundreds of millions of vaccines to help blunt the coronavirus, cyber-criminals continue to leverage the urgency and despair of the global pandemic for intelligence and monetary gain. In this case, the phishing scheme spanned six countries and targeted European organizations that bolster immunization in poor countries.In late November, the Atlanta-based cold chain company Americold Realty Trust said it was the target of a cyber-attack. The company believes the attack has been contained, but hadn’t “completed its investigation,” Americold said in a Nov. 30 regulatory filing. The company didn’t expect the hack to impact operations.Americold didn’t respond to requests for comment on the scope of the attack and the role email phishing may have played.Covid-19 phishing emails are one of the most prolific scams in recent memory. Since late-January, attackers have duped recipients into opening emails with subject lines related to the virus. And victims the world over, living in fear of the pandemic and its economic impact, have opened these emails and clicked on their infected links and attachments. Doing so has led to compromises of individual devices and corporate networks, and ultimately to the theft of personal and company data. Employees working from home during the pandemic without sufficient cybersecurity protections have exacerbated these problems.“As we shift toward distributing a vaccine for Covid-19, the logistics of this operation will become extremely critical,” said John Hultquist, a senior director at the cybersecurity firm FireEye Inc. “Seemingly mundane security issues could have major repercussions to such a complex and important effort.”As Pfizer Inc. and Moderna Inc. work with U.S. and global regulators to approve their Covid-19 vaccines for emergency use, global distribution has already started. Pfizer and United Airlines transported the first mass air shipment of a vaccine from Brussels to Chicago in late November.Pfizer’s vaccine must be stored at ultra-cold temperatures to avoid contamination. But maintaining temperature controls once a vaccine leaves the airplane remains a challenge. In parts of West Africa, for instance, temperatures in mid-December range from 70 to 90 degrees Fahrenheit. Even states in the U.S. lack necessary capacity to store large volumes of the vaccine without spoiling.This makes cold chain companies like China’s Haier essential to global distribution. It also makes them prime targets for spoofing campaigns, said Claire Zaboeva, senior cyber threat analyst at IBM’s Security X-ForceTargets of the phishing operation have included the European Commission’s Directorate-General for Taxation and Customs Union, according to IBM. The agency is responsible for streamlining customs and duties as goods travel across the European Union. Attackers may see the agency as a single point of compromise to disrupt distribution across the region.Petrochemical companies were also targeted, since they produce dry ice to keep vials cool.“This was a well-prepared, precise, sophisticated campaign,” said Nick Rossmann, global lead for threat intelligence at IBM Security X-Force. “We can’t ignore the fact that there are actors who will benefit from disrupting distribution of the vaccine. If an actor could disrupt consumer trust in the vaccine, that could play a pivotal role in changing perceptions of world power.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Cybersecurity needs are soaring as we spend more time online, and that has driven Crowdstrike Holdings Inc (NASDAQ:CRWD) results and outlook higher. Fiscal 2021 third quarter saw 87% subscription revenue growth from a year earlier and a record net new 1,186 subscription customers for a total of 8,416. Earnings per share of 8 cents beat the estimate of zero cents on sales of $232.46 million, which compares to analyst expectations of $214 million.